97 results
Page 2 of 5
8-K
382cxch0492w7yer
7 Sep 21
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
7:08am
S-3ASR
EX-1.2
quvucvn0tahhja w11w
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-5.2
bx5024g16vua2pv1
10 Aug 20
Automatic shelf registration
5:01pm
8-K
EX-1.1
cwwihaz
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
sqm8 8czwigj1la
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-1.1
fd5roa5vmbzphrvky54t
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
z32ehep
21 Jan 20
Prospectus supplement for primary offering
5:21pm